Home
- Naturade Significantly Strengthens Balance Sheet; Receives $2.5 Million in Capital from Westgate Equity Partners, L.P.
- Natrol Appoints Vincent Andrich VP Sales for Prolab Division
- Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results
- Body Shop Reports 24.8 Mil Euro Sales Revenues
- Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label
- Supplement Group Targets Consumer Education
- Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing
- ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market
- Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products
- Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth
- Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities
- ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products
- Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace
- Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO
- drugstore.com Expects to Reach Profitability Target in 2003
- Human Genome Project Leads to Innovative Healthcare
- NPIcenter’s Career Center targets nutraceutical Industry
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Editorial: An Exercise in Synergy
- NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway
- Natural Health Trends Corp. Launches Lexxus Taiwan
- FDA Presents Compliance Guide for Structure/Function Claims
- New TrimFit® Bars Redefine Energy Bar Category
- New TrimFit® Bars Redefine Energy Bar Category
- Probiata® Offers Safe, Natural and Effective Alternative
- Alive & Well with Michelle Harris
- Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com
- Consumers Search for Healthy Cleaning Products That Work
- Nordic Naturals: Omega 3 Fatty Acids
- Cyanotech Names Bob Capelli as Director of Sales
- Bonkers(TM) Performance Teas Introduces Brain Boost With SerinAid® & Bacopa And Maximum Performance Super Energizer With AlphaSize® & Guarana
Company introduces mental performance enhancing teas that deliver useful amounts of both phosphatidylserine (PS) and alpha-glyceryl phosphoryl choline (A-GPC).
- Bonkers(TM) Performance Teas Introduces Brain Boost With SerinAid® & Bacopa And Maximum Performance Super Energizer With AlphaSize® & Guarana
Company introduces mental performance enhancing teas that deliver useful amounts of both phosphatidylserine (PS) and alpha-glyceryl phosphoryl choline (A-GPC).
- Bonkers(TM) Performance Teas Introduces Brain Boost With SerinAid® & Bacopa And Maximum Performance Super Energizer With AlphaSize® & Guarana
Company introduces mental performance enhancing teas that deliver useful amounts of both phosphatidylserine (PS) and alpha-glyceryl phosphoryl choline (A-GPC).
- Bonkers(TM) Performance Teas Introduces Brain Boost With SerinAid® & Bacopa And Maximum Performance Super Energizer With AlphaSize® & Guarana
Company introduces mental performance enhancing teas that deliver useful amounts of both phosphatidylserine (PS) and alpha-glyceryl phosphoryl choline (A-GPC).
- Bonkers(TM) Performance Teas Introduces Brain Boost With SerinAid® & Bacopa And Maximum Performance Super Energizer With AlphaSize® & Guarana
Company introduces mental performance enhancing teas that deliver useful amounts of both phosphatidylserine (PS) and alpha-glyceryl phosphoryl choline (A-GPC).
- Bonkers(TM) Performance Teas Introduces Brain Boost With SerinAid® & Bacopa And Maximum Performance Super Energizer With AlphaSize® & Guarana
Company introduces mental performance enhancing teas that deliver useful amounts of both phosphatidylserine (PS) and alpha-glyceryl phosphoryl choline (A-GPC).
- IdeaSphere Obtains Exclusive Worldwide License** to Weil Nutritional Supplements
Company announces that it has reached an agreement in principle with Weil Lifestyle to assume exclusive, worldwide licensing rights to Weil Nutritional Supplements (exclusing Canada).
- IdeaSphere Obtains Exclusive Worldwide License** to Weil Nutritional Supplements
Company announces that it has reached an agreement in principle with Weil Lifestyle to assume exclusive, worldwide licensing rights to Weil Nutritional Supplements (exclusing Canada).
- IdeaSphere Obtains Exclusive Worldwide License** to Weil Nutritional Supplements
Company announces that it has reached an agreement in principle with Weil Lifestyle to assume exclusive, worldwide licensing rights to Weil Nutritional Supplements (exclusing Canada).
- IdeaSphere Obtains Exclusive Worldwide License** to Weil Nutritional Supplements
Company announces that it has reached an agreement in principle with Weil Lifestyle to assume exclusive, worldwide licensing rights to Weil Nutritional Supplements (exclusing Canada).
- IdeaSphere Obtains Exclusive Worldwide License** to Weil Nutritional Supplements
Company announces that it has reached an agreement in principle with Weil Lifestyle to assume exclusive, worldwide licensing rights to Weil Nutritional Supplements (exclusing Canada).
- IdeaSphere Obtains Exclusive Worldwide License** to Weil Nutritional Supplements
Company announces that it has reached an agreement in principle with Weil Lifestyle to assume exclusive, worldwide licensing rights to Weil Nutritional Supplements (exclusing Canada).
- IdeaSphere Obtains Exclusive Worldwide License** to Weil Nutritional Supplements
Company announces that it has reached an agreement in principle with Weil Lifestyle to assume exclusive, worldwide licensing rights to Weil Nutritional Supplements (exclusing Canada).
- IdeaSphere Obtains Exclusive Worldwide License** to Weil Nutritional Supplements
Company announces that it has reached an agreement in principle with Weil Lifestyle to assume exclusive, worldwide licensing rights to Weil Nutritional Supplements (exclusing Canada).
- Indena's Cosmetic Fluid Extract Lines to Move to Greentech
Indena has disclosed today a preliminary agreement to transfer its cosmetic fluid extract lines, including its brands PHYTELENES® and COSMELENE®, to the French phytocosmetic specialists Greentech S.A..
- Indena's Cosmetic Fluid Extract Lines to Move to Greentech
Indena has disclosed today a preliminary agreement to transfer its cosmetic fluid extract lines, including its brands PHYTELENES® and COSMELENE®, to the French phytocosmetic specialists Greentech S.A..
- Indena's Cosmetic Fluid Extract Lines to Move to Greentech
Indena has disclosed today a preliminary agreement to transfer its cosmetic fluid extract lines, including its brands PHYTELENES® and COSMELENE®, to the French phytocosmetic specialists Greentech S.A..
- Indena's Cosmetic Fluid Extract Lines to Move to Greentech
Indena has disclosed today a preliminary agreement to transfer its cosmetic fluid extract lines, including its brands PHYTELENES® and COSMELENE®, to the French phytocosmetic specialists Greentech S.A..
- Indena's Cosmetic Fluid Extract Lines to Move to Greentech
Indena has disclosed today a preliminary agreement to transfer its cosmetic fluid extract lines, including its brands PHYTELENES® and COSMELENE®, to the French phytocosmetic specialists Greentech S.A..
- Indena's Cosmetic Fluid Extract Lines to Move to Greentech
Indena has disclosed today a preliminary agreement to transfer its cosmetic fluid extract lines, including its brands PHYTELENES® and COSMELENE®, to the French phytocosmetic specialists Greentech S.A..
- Natural Cold Medicine Shortens Duration of Acute Bronchitis, New Study Finds
randomized, double-blind, placebo-controlled trial, published in the medical journal EXPLORE -- The Journal of Science and Healing shows that a medicinal extract of Pelargonium sidoides roots, available in the U.S. as UMCKA COLDCARE(R), evaluated for efficacy of treatment for chronic bronchitis, resulted in complete recovery or major improvement in 85% of patients, compared to just 30% for placebo.
- Natural Cold Medicine Shortens Duration of Acute Bronchitis, New Study Finds
randomized, double-blind, placebo-controlled trial, published in the medical journal EXPLORE -- The Journal of Science and Healing shows that a medicinal extract of Pelargonium sidoides roots, available in the U.S. as UMCKA COLDCARE(R), evaluated for efficacy of treatment for chronic bronchitis, resulted in complete recovery or major improvement in 85% of patients, compared to just 30% for placebo.
- Natural Cold Medicine Shortens Duration of Acute Bronchitis, New Study Finds
randomized, double-blind, placebo-controlled trial, published in the medical journal EXPLORE -- The Journal of Science and Healing shows that a medicinal extract of Pelargonium sidoides roots, available in the U.S. as UMCKA COLDCARE(R), evaluated for efficacy of treatment for chronic bronchitis, resulted in complete recovery or major improvement in 85% of patients, compared to just 30% for placebo.
- Natural Cold Medicine Shortens Duration of Acute Bronchitis, New Study Finds
randomized, double-blind, placebo-controlled trial, published in the medical journal EXPLORE -- The Journal of Science and Healing shows that a medicinal extract of Pelargonium sidoides roots, available in the U.S. as UMCKA COLDCARE(R), evaluated for efficacy of treatment for chronic bronchitis, resulted in complete recovery or major improvement in 85% of patients, compared to just 30% for placebo.
- Natural Cold Medicine Shortens Duration of Acute Bronchitis, New Study Finds
randomized, double-blind, placebo-controlled trial, published in the medical journal EXPLORE -- The Journal of Science and Healing shows that a medicinal extract of Pelargonium sidoides roots, available in the U.S. as UMCKA COLDCARE(R), evaluated for efficacy of treatment for chronic bronchitis, resulted in complete recovery or major improvement in 85% of patients, compared to just 30% for placebo.
- New Study Finds Cranberry Compounds Block Cancer
New study, published in this month's issue of The Journal of the Science of Food and Agriculture, shows that proanthocyanidins, or PACs, found in cranberries inhibit the growth of lung tumors and colon and leukemia cells in vitro.
- New Study Finds Cranberry Compounds Block Cancer
New study, published in this month's issue of The Journal of the Science of Food and Agriculture, shows that proanthocyanidins, or PACs, found in cranberries inhibit the growth of lung tumors and colon and leukemia cells in vitro.
- New Study Finds Cranberry Compounds Block Cancer
New study, published in this month's issue of The Journal of the Science of Food and Agriculture, shows that proanthocyanidins, or PACs, found in cranberries inhibit the growth of lung tumors and colon and leukemia cells in vitro.
- New Study Finds Cranberry Compounds Block Cancer
New study, published in this month's issue of The Journal of the Science of Food and Agriculture, shows that proanthocyanidins, or PACs, found in cranberries inhibit the growth of lung tumors and colon and leukemia cells in vitro.
- New Study Finds Cranberry Compounds Block Cancer
New study, published in this month's issue of The Journal of the Science of Food and Agriculture, shows that proanthocyanidins, or PACs, found in cranberries inhibit the growth of lung tumors and colon and leukemia cells in vitro.
- New Study Finds Cranberry Compounds Block Cancer
New study, published in this month's issue of The Journal of the Science of Food and Agriculture, shows that proanthocyanidins, or PACs, found in cranberries inhibit the growth of lung tumors and colon and leukemia cells in vitro.
- New Study Finds Cranberry Compounds Block Cancer
New study, published in this month's issue of The Journal of the Science of Food and Agriculture, shows that proanthocyanidins, or PACs, found in cranberries inhibit the growth of lung tumors and colon and leukemia cells in vitro.
- Lipid Nutrition Acquires PharmaNutrients’ CLA One Business
Lipid Nutrition has signed an agreement to acquire PharmaNutrients’ CLA One® business effective February 1, 2006.
- Lipid Nutrition Acquires PharmaNutrients’ CLA One Business
Lipid Nutrition has signed an agreement to acquire PharmaNutrients’ CLA One® business effective February 1, 2006.
- Lipid Nutrition Acquires PharmaNutrients’ CLA One Business
Lipid Nutrition has signed an agreement to acquire PharmaNutrients’ CLA One® business effective February 1, 2006.
- Zuellig Appoints George Pontiakos President and CEO of North American Operations
Company announces the appointment of George M. Pontiakos to President and CEO of Zuellig Group North America, to oversee all aspects of North American operations including BI Nutraceuticals, Premium Performance Ingredients, AF Zeta and the Zuellig Group Nutrition and Ingredients, China.
- Zuellig Appoints George Pontiakos President and CEO of North American Operations
Company announces the appointment of George M. Pontiakos to President and CEO of Zuellig Group North America, to oversee all aspects of North American operations including BI Nutraceuticals, Premium Performance Ingredients, AF Zeta and the Zuellig Group Nutrition and Ingredients, China.
- Zuellig Appoints George Pontiakos President and CEO of North American Operations
Company announces the appointment of George M. Pontiakos to President and CEO of Zuellig Group North America, to oversee all aspects of North American operations including BI Nutraceuticals, Premium Performance Ingredients, AF Zeta and the Zuellig Group Nutrition and Ingredients, China.
- Zuellig Appoints George Pontiakos President and CEO of North American Operations
Company announces the appointment of George M. Pontiakos to President and CEO of Zuellig Group North America, to oversee all aspects of North American operations including BI Nutraceuticals, Premium Performance Ingredients, AF Zeta and the Zuellig Group Nutrition and Ingredients, China.
- Zuellig Appoints George Pontiakos President and CEO of North American Operations
Company announces the appointment of George M. Pontiakos to President and CEO of Zuellig Group North America, to oversee all aspects of North American operations including BI Nutraceuticals, Premium Performance Ingredients, AF Zeta and the Zuellig Group Nutrition and Ingredients, China.
- NHPRS Annual Research Conference and Tradeshow Focuses on the Latest Research Advances
The conference, to be held March 3-5, 2006, Toronto, Ontario, Canada, at the Downtown Marriott Eaton's Centre, features keynote addresses from the world's leading natural health product (NHP) experts and the latest research advances peer-selected from a global call for papers.
- NHPRS Annual Research Conference and Tradeshow Focuses on the Latest Research Advances
The conference, to be held March 3-5, 2006, Toronto, Ontario, Canada, at the Downtown Marriott Eaton's Centre, features keynote addresses from the world's leading natural health product (NHP) experts and the latest research advances peer-selected from a global call for papers.
- NHPRS Annual Research Conference and Tradeshow Focuses on the Latest Research Advances
The conference, to be held March 3-5, 2006, Toronto, Ontario, Canada, at the Downtown Marriott Eaton's Centre, features keynote addresses from the world's leading natural health product (NHP) experts and the latest research advances peer-selected from a global call for papers.
- NHPRS Annual Research Conference and Tradeshow Focuses on the Latest Research Advances
The conference, to be held March 3-5, 2006, Toronto, Ontario, Canada, at the Downtown Marriott Eaton's Centre, features keynote addresses from the world's leading natural health product (NHP) experts and the latest research advances peer-selected from a global call for papers.
- NHPRS Annual Research Conference and Tradeshow Focuses on the Latest Research Advances
The conference, to be held March 3-5, 2006, Toronto, Ontario, Canada, at the Downtown Marriott Eaton's Centre, features keynote addresses from the world's leading natural health product (NHP) experts and the latest research advances peer-selected from a global call for papers.
- Unigen Pharmaceuticals Hires Director of Clinical Research
Unigen Pharmaceuticals, Inc. has announced the hiring of the company’s first Director of Clinical Research, Terry E. O’Reilly, M.D.
- Unigen Pharmaceuticals Hires Director of Clinical Research
Unigen Pharmaceuticals, Inc. has announced the hiring of the company’s first Director of Clinical Research, Terry E. O’Reilly, M.D.
- Unigen Pharmaceuticals Hires Director of Clinical Research
Unigen Pharmaceuticals, Inc. has announced the hiring of the company’s first Director of Clinical Research, Terry E. O’Reilly, M.D.
- Unigen Pharmaceuticals Hires Director of Clinical Research
Unigen Pharmaceuticals, Inc. has announced the hiring of the company’s first Director of Clinical Research, Terry E. O’Reilly, M.D.
- Unigen Pharmaceuticals Hires Director of Clinical Research
Unigen Pharmaceuticals, Inc. has announced the hiring of the company’s first Director of Clinical Research, Terry E. O’Reilly, M.D.
- MidOcean Partners Agrees to Sell Majority Stake in Vitaquest International to CK Life Sciences
MidOcean Partners has announced the signing of a definitive agreement to sell its majority stake in Vitaquest to an affiliate of CK Life Sciences Int'l., Inc., in a transaction that values Vitaquest at a total enterprise value of $345 million.
- MidOcean Partners Agrees to Sell Majority Stake in Vitaquest International to CK Life Sciences
MidOcean Partners has announced the signing of a definitive agreement to sell its majority stake in Vitaquest to an affiliate of CK Life Sciences Int'l., Inc., in a transaction that values Vitaquest at a total enterprise value of $345 million.
- MidOcean Partners Agrees to Sell Majority Stake in Vitaquest International to CK Life Sciences
MidOcean Partners has announced the signing of a definitive agreement to sell its majority stake in Vitaquest to an affiliate of CK Life Sciences Int'l., Inc., in a transaction that values Vitaquest at a total enterprise value of $345 million.
- Yasoo Health, Inc. Receives Nearly $1 Million to Develop Novel Nutritional Formulation
Company received $936,375 in financing from the Cystic Fibrosis Foundation to develop and commercialize a formulation that addresses a key nutritional problem of poor fat-soluble vitamin and nutrient absorption in cystic fibrosis patients.
- Yasoo Health, Inc. Receives Nearly $1 Million to Develop Novel Nutritional Formulation
Company received $936,375 in financing from the Cystic Fibrosis Foundation to develop and commercialize a formulation that addresses a key nutritional problem of poor fat-soluble vitamin and nutrient absorption in cystic fibrosis patients.
- Yasoo Health, Inc. Receives Nearly $1 Million to Develop Novel Nutritional Formulation
Company received $936,375 in financing from the Cystic Fibrosis Foundation to develop and commercialize a formulation that addresses a key nutritional problem of poor fat-soluble vitamin and nutrient absorption in cystic fibrosis patients.
- Yasoo Health, Inc. Receives Nearly $1 Million to Develop Novel Nutritional Formulation
Company received $936,375 in financing from the Cystic Fibrosis Foundation to develop and commercialize a formulation that addresses a key nutritional problem of poor fat-soluble vitamin and nutrient absorption in cystic fibrosis patients.
- Yasoo Health, Inc. Receives Nearly $1 Million to Develop Novel Nutritional Formulation
Company received $936,375 in financing from the Cystic Fibrosis Foundation to develop and commercialize a formulation that addresses a key nutritional problem of poor fat-soluble vitamin and nutrient absorption in cystic fibrosis patients.
- Yasoo Health, Inc. Receives Nearly $1 Million to Develop Novel Nutritional Formulation
Company received $936,375 in financing from the Cystic Fibrosis Foundation to develop and commercialize a formulation that addresses a key nutritional problem of poor fat-soluble vitamin and nutrient absorption in cystic fibrosis patients.
- Yasoo Health, Inc. Receives Nearly $1 Million to Develop Novel Nutritional Formulation
Company received $936,375 in financing from the Cystic Fibrosis Foundation to develop and commercialize a formulation that addresses a key nutritional problem of poor fat-soluble vitamin and nutrient absorption in cystic fibrosis patients.
- Jarrow Industries, Inc. Achieves International Good Manufacturing Practices (GMP) Registration
Company has announced that it has achieved Good Manufacturing Practices (GMP) Registration through NSF International’s Dietary Supplement Certification program.
- Jarrow Industries, Inc. Achieves International Good Manufacturing Practices (GMP) Registration
Company has announced that it has achieved Good Manufacturing Practices (GMP) Registration through NSF International’s Dietary Supplement Certification program.
- Jarrow Industries, Inc. Achieves International Good Manufacturing Practices (GMP) Registration
Company has announced that it has achieved Good Manufacturing Practices (GMP) Registration through NSF International’s Dietary Supplement Certification program.
- Jarrow Industries, Inc. Achieves International Good Manufacturing Practices (GMP) Registration
Company has announced that it has achieved Good Manufacturing Practices (GMP) Registration through NSF International’s Dietary Supplement Certification program.
- CK Life Sciences Spends $1.3b (US$166 million) to Expand into US Nutraceutical Market
CK Life Sciences Int’l., Inc. will acquire an 80% direct interest in Vitaquest at a purchase price of HK$1,291.5 million (US$166 million), subject to adjustment at closing.
- CK Life Sciences Spends $1.3b (US$166 million) to Expand into US Nutraceutical Market
CK Life Sciences Int’l., Inc. will acquire an 80% direct interest in Vitaquest at a purchase price of HK$1,291.5 million (US$166 million), subject to adjustment at closing.
- CK Life Sciences Spends $1.3b (US$166 million) to Expand into US Nutraceutical Market
CK Life Sciences Int’l., Inc. will acquire an 80% direct interest in Vitaquest at a purchase price of HK$1,291.5 million (US$166 million), subject to adjustment at closing.
- HerbDay 2006 Scheduled for October 14th - Events Planned to 'Celebrate Herbs and Herbalism'
Five national non-profit organizations working together as the HerbDay Coalition announced today that the first annual HerbDay will be held on Saturday, October 14, 2006 - HerbDay is a coordinated series of public educational events celebrating the importance of herbs and herbalism, with activities occurring at retail stores, botanical gardens and parks throughout North America.
- HerbDay 2006 Scheduled for October 14th - Events Planned to 'Celebrate Herbs and Herbalism'
Five national non-profit organizations working together as the HerbDay Coalition announced today that the first annual HerbDay will be held on Saturday, October 14, 2006 - HerbDay is a coordinated series of public educational events celebrating the importance of herbs and herbalism, with activities occurring at retail stores, botanical gardens and parks throughout North America.
- HerbDay 2006 Scheduled for October 14th - Events Planned to 'Celebrate Herbs and Herbalism'
Five national non-profit organizations working together as the HerbDay Coalition announced today that the first annual HerbDay will be held on Saturday, October 14, 2006 - HerbDay is a coordinated series of public educational events celebrating the importance of herbs and herbalism, with activities occurring at retail stores, botanical gardens and parks throughout North America.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators
Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
- NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators
Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Spotlight on Savory Side Dishes
- Spotlight on Savory Side Dishes
- Spotlight on Savory Side Dishes
- Another Reason to Choose Healthy Lifestyle Habits
- Another Reason to Choose Healthy Lifestyle Habits
|
Chicago, IL January 25, 2006---Karen Weaver, and her two associates, formerly of the Weaver Law Group, LLC, are the newest attorneys to join the Chicago office of Epstein Becker and Green, P.C. (EBG). These additions bring a remarkable set of skills and extensive legal experience in a wide variety of disciplines and endeavors. Karen Weaver specializes in the life science industry and brings responsive and sound legal representation to the natural products, food, and drug industries, as well as advertising and marketing claims related to those products.
Weaver, now a member of the firm at Epstein Becker & Green, P.C., advises clients on regulatory compliance, advertising, and multi-level marketing matters, and represents clients before both federal and state administrative and judicial bodies. She also devotes a portion of her practice to intellectual property and commercial litigation.
“Ms. Weaver is a talented, dedicated, and multi-faceted attorney,” said Diane Romza-Kutz, managing partner at EBG Chicago. “We are very pleased to have Ms. Weaver join us as she brings additional depth and strength to our FDA, food, and Life Science practice.”
In addition to forming Weaver Law Group, Weaver has been an associate and then founding partner at two food and drug law firms, and has served as in-house litigation counsel for a Fortune 100 corporation. She has successfully negotiated favorable results for her clients in actions brought by the Federal Trade Commission, Food and Drug Administration, United States Postal Service, and other state enforcement bodies.
Weaver currently teaches Food and Drug Law at DePaul University and is a sought-after lecturer, having presented lectures on topics as diverse as cosmetic regulation, pet food enforcement, defending FTC actions, and FDA’s proposed dietary supplement GMP’s.
Weaver, also a registered pharmacist, had previously served as executive vice president for a privately held corporation providing pharmacokinetic drug dosing services. Weaver was responsible for strategy development and program execution for pharmacies across the nation involved in a joint venture with her employer, Baxter International, and Sandoz Pharmaceuticals. She has also sold pharmaceutical products for Schering-Plough.
Weaver received her J.D. from DePaul University College of Law, Chicago, Illinois with a certificate in Healthcare Law. She received a B.S. in Pharmacy from the University of Toledo, Ohio where she was president of her professional fraternity, played division I-A basketball, and received the Upjohn Pharmacy Intern Award. Weaver also served in the U.S. Armed Forces where she was decorated with the Army Commendation Medal.
“Ms. Weaver’s broad range of interests and experience is a valuable addition to EBG,” said Romza-Kutz.
About Epstein Becker & Green, P.C.
Founded in 1973, Epstein Becker & Green, P.C., is a law firm with more than 380 attorneys practicing in 11 offices throughout the U.S. -- Atlanta, Chicago, Dallas, Houston, Los Angeles, Miami, New York, Newark, San Francisco, Stamford, and Washington, D.C. -- and affiliations worldwide. The firm's size, diversity, and global affiliations allow its attorneys to address the needs of both small entrepreneurial ventures and large multinational corporations on a worldwide basis, including domestic, Fortune 100, middle market, and international affiliates.
### |